Nicotine and Expanded Metabolites, LC/MS/MS
There are no preparation instructions.
- $82.95
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Nicotine and Expanded Metabolites, LC/MS/MS #90983
3 Biomarkers - Specimen Type: Varied - Process Time*: Average 5 to 6 business days
Also known as: Nicotine and Expanded Metabolites LCMSMS
Biomarkers 3
3oh Cotinine,Serum/Plasma
Cotinine, Serum/Plasma
Nicotine, Serum/Plasma
*Important Information on Lab Test Processing Times: Ulta Lab Tests is committed to informing you about the processing times for your lab tests processed through a national lab. Please note that the estimated processing time for each test, indicated in business days, is based on data from the past 30 days across the 13 laboratories for each test. These estimates are intended to serve as a guide and are not guarantees. Factors such as laboratory workload, weather conditions, holidays, and the need for additional testing or maintenance can influence actual processing times. We aim to offer estimates to help you plan accordingly. Please understand that these times may vary, and processing times are not guaranteed. Thank you for choosing Ulta Lab Tests for your laboratory needs.
The Nicotine and Expanded Metabolites, LC/MS/MS test contains 1 test with 3 biomarkers.
This assay is used for the detection of nicotine and two primary metabolites, 3-OH cotinine and cotinine in serum and plasma to determine the tobacco exposure status of an individual. Nicotine has a short half-life of approximately sixty minutes; Its presence may indicate recent tobacco exposure. The half-life of the primary metabolites is longer and provides a larger window of detection for tobacco exposure. Individuals exposed to passive tobacco smoke (environmental or second-hand) can have detectable concentrations of nicotine and its metabolites depending on the type of exposure. The ranges of concentrations related to passive exposure are not well established but normally are less than those attributed to active tobacco users.